Bristol-Myers Squibb Reports First Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Bristol-Myers Squibb (BMY) Tops Q1 EPS by 1c, Maintains EPS Guidance
April 25, 2019 7:00 AM EDTBristol-Myers Squibb (NYSE: BMY) reported Q1 EPS of $1.10, $0.01 better than the analyst estimate of $1.09. Revenue for the quarter came in at $5.92 billion versus the consensus estimate of $5.76 billion.
GUIDANCE:
Bristol-Myers Squibb sees FY2019 EPS of $4.10-$4.20, versus the consensus of... More
